Pyrocurzerenone suppresses human oral cancer cell metastasis by inhibiting the expression of ERK1 /2 and cathepsin S proteins
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.70015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Ming-Ju Hsieh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Oral Cancer Research Center, Changhua Christian Hospital, Changhua, Taiwan. Hauptthemen laut MEDLINE: Mouth Neoplasms, Cell Movement, Cathepsins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pyrocurzerenone is a natural compound found in Curcuma zedoaria and Chloranthus serratus . However, the anticancer effect of pyrocurzerenone in oral cancer remains unclear. Using the MTT assay, wound healing assay, transwell assay and western blot analysis, we investigated the impact of pyrocurzerenone on antimetastatic activity, as well as the critical signalling pathways that underlie the processes of oral cancer cell lines SCC‐9, SCC‐1 and SAS in this work. Our findings suggested that pyrocurzerenone inhibits cell migration and invasion ability in oral cancer cell lines. Furthermore, phosphorylation of ERK1/2 had significant inhibitory effects in SCC‐9 and SCC‐1 cell lines. Combining ERK1/2 inhibitors with pyrocurzerenone decreased the migration and invasion activity of SCC‐9 and SCC‐1 cell lines. We also found that the expressed level of cathepsin S decreased under pyrocurzerenone treatment. This study showed that pyrocurzerenone reduced ERK1/2 expression of the proteins and cathepsin S, suggesting that it could be a valuable treatment to inhibit human oral cancer cell metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oral Cancer Research Center, Changhua Christian Hospital, Changhua, Taiwan.
- Graduate Institute of Clinical Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
- Doctoral Program in Tissue Engineering and Regenerative Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
- Department of Otorhinolaryngology, Head and Neck Surgery, Changhua Christian Hospital, Changhua, Taiwan.
ORCID-Profile: Ming-Ju Hsieh, Chia-Chieh Lin
Zitieren
APA
Hsieh, M. J., Lin, C. C., Ho, H. Y., Chuang, Y. C., Lo, Y. S., & Chen, M. K. (2024). Pyrocurzerenone suppresses human oral cancer cell metastasis by inhibiting the expression of ERK1 /2 and cathepsin S proteins. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70015
Vancouver
Hsieh MJ, Lin CC, Ho HY, Chuang YC, Lo YS, Chen MK. Pyrocurzerenone suppresses human oral cancer cell metastasis by inhibiting the expression of ERK1 /2 and cathepsin S proteins. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70015
BibTeX
@article{Hsieh2024,
author = {Hsieh, Ming-Ju and Lin, Chia-Chieh and Ho, Hsin-Yu and Chuang, Yi-Ching and Lo, Yu-Sheng and Chen, Mu-Kuan},
title = {Pyrocurzerenone suppresses human oral cancer cell metastasis by inhibiting the expression of ERK1 /2 and cathepsin S proteins},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.70015}
}
EUVIMED